Corporate Actions

Aspira Pathlab plans Rs 65 crore rights issue to eligible shareholders

12-Sep-26   17:52 Hrs IST

Aspira Pathlab & Diagnostics Limited plans to raise up to Rs 65,00,00,000 through a rights issue to eligible equity shareholders, potentially offering equity or convertible instruments, subject to shareholder and regulatory approvals, with the issue price, entitlement ratio, and record date to be determined later. The board has also constituted a Right Issue Committee, comprised of Mr. Nikunj Velji Mange (Chairman), Mr. Vaibhav Odhekar, Mrs. Kiran Raghavendra awasthi, and Mr. Balkrishna Subhash Talawadekar, to finalize the terms and conditions of the rights offering.

Attention Investors:

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. || Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. || Pay 20% upfront margin of the transaction value to trade in cash market segment. || Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. || Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. || KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. || No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.